STEFAN OCTAVIAN CIUREA to Interleukins
This is a "connection" page, showing publications STEFAN OCTAVIAN CIUREA has written about Interleukins.
Connection Strength
0.487
-
Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation. Blood. 2017 10 19; 130(16):1857-1868.
Score: 0.487
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.